These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prophylactic effect of topical fluoroquinolones in a rabbit model of Staphylococcus aureus endophthalmitis. Wu X, Chen H, Jiang H, Xu Y, Liu T, Xu L. J Ocul Pharmacol Ther; 2012 Apr; 28(2):186-93. PubMed ID: 22077488 [Abstract] [Full Text] [Related]
31. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series. Moshirfar M, Feiz V, Vitale AT, Wegelin JA, Basavanthappa S, Wolsey DH. Ophthalmology; 2007 Apr; 114(4):686-91. PubMed ID: 17184840 [Abstract] [Full Text] [Related]
38. Microbiota evaluation of patients with a Boston type I keratoprosthesis treated with topical 0.5% moxifloxacin and 5% povidone-iodine. Magalhães FP, do Nascimento HM, Ecker DJ, Sannes-Lowery KA, Sampath R, Rosenblatt MI, de Sousa LB, de Oliveira LA. Cornea; 2013 Apr; 32(4):407-11. PubMed ID: 22488148 [Abstract] [Full Text] [Related]
39. Laboratory data and statistical evidence in fluoroquinolone study. O'Callaghan R, Ohnsman C, Song J. J Cataract Refract Surg; 2008 Oct; 34(10):1617-8; author reply 1618. PubMed ID: 18812096 [No Abstract] [Full Text] [Related]